Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HERBST

Showing results (371-380 of 4,446) with videos related to

Pageof 445
Sort By:
Clinical Lung Cancer|November 20, 2003
Integration of targeted therapies in gemcitabine chemotherapy regimensGeorge R Blumenschein, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Targeting the epidermal growth factor receptor in non-small cell lung cancerRoy S Herbst, Paul A Bunn
Der Pathologe|February 10, 2004
[Salivary gland lymphomas]M Tiemann, A Teymoortash, H Herbst
Clinical Laboratory|March 6, 2004
Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassayJürgen Westermann, Anke Demir, Victor Herbst
Foot and Ankle Clinics|October 23, 2004
Osteonecrosis of the talusChristopher P Chiodo, Steven A Herbst
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|December 31, 2005
Local heat flux and energy loss in a two-dimensional vibrated granular gasOlaf Herbst, Peter Müller, Annette Zippelius
Children and Youth Services Review|June 11, 2013
Can We Trust Parental Reports of Child Care Subsidy Receipt?Anna D Johnson, Chris M Herbst
Southern Medical Journal|April 1, 1983
Perforated neonatal appendicitisG R Schorlemmer, C A Herbst
Seminars in Oncology|March 15, 2002
Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancersRoy S Herbst, Corey J Langer
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Gefitinib: current and future status in cancer therapyRoy S Herbst, Merrill S Kies
Pageof 445

Showing results (371-380 of 4,446) with videos related to

Sort By:
Pageof 445
Clinical Lung Cancer|November 20, 2003
Integration of targeted therapies in gemcitabine chemotherapy regimensGeorge R Blumenschein, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Targeting the epidermal growth factor receptor in non-small cell lung cancerRoy S Herbst, Paul A Bunn
Der Pathologe|February 10, 2004
[Salivary gland lymphomas]M Tiemann, A Teymoortash, H Herbst
Clinical Laboratory|March 6, 2004
Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassayJürgen Westermann, Anke Demir, Victor Herbst
Foot and Ankle Clinics|October 23, 2004
Osteonecrosis of the talusChristopher P Chiodo, Steven A Herbst
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|December 31, 2005
Local heat flux and energy loss in a two-dimensional vibrated granular gasOlaf Herbst, Peter Müller, Annette Zippelius
Children and Youth Services Review|June 11, 2013
Can We Trust Parental Reports of Child Care Subsidy Receipt?Anna D Johnson, Chris M Herbst
Southern Medical Journal|April 1, 1983
Perforated neonatal appendicitisG R Schorlemmer, C A Herbst
Seminars in Oncology|March 15, 2002
Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancersRoy S Herbst, Corey J Langer
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Gefitinib: current and future status in cancer therapyRoy S Herbst, Merrill S Kies
Pageof 445